You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The university also is developing a process for measuring phenotype risk scores as it continually adapts to changing technology and research needs.
With $200M in new investment, the precision medicine firm has launched a clinical trial matching service, is adding clinical data to TCGA, and is moving into the Asian market.
The company formerly known as TransMed Systems looks to bring "clarity and transparency" to the emerging field of precision oncology and in patient-trial matching.
AWS joins Google Cloud in supporting STRIDES, a nascent NIH program aimed at reducing barriers to large-scale biomedical data analysis via cloud computing.
The All of Us Participant Technology Systems Center offers web and mobile apps to aggregate data and engage patients who join the All of Us cohort program.
During a two-year pilot, the Genomic Ascertainment Cohort will collect 10,000 genotypes and make patients available for follow-up exams to confirm predictions.
The company plans to develop a liquid biopsy assay that can identify patients most likely to benefit from treatment with checkpoint inhibitors.
The National Cancer Institute is accepting proposals from groups interested in producing affinity binders for the agency's Antibody Characterization Program.
The program will use transcriptomics, proteomics, lipidomics, and metabolomics to explore immune response.
The NIH award funds a database that catalogs genomic information of clinically, economically, and scientifically important eukaryotic pathogens.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.